Chris Toth

President, Varian Oncology Systems


Chris Toth joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during his nearly two-decade tenure with the company.

In October of 2018, Mr. Toth was named president of Varian Oncology Systems. Prior to this appointment, he served as president of Global Commercial and Field Operations, where he was responsible for global sales strategy and execution for Varian's Oncology and Proton Therapy businesses. Additionally, he was responsible for global field service, applications training, market access and regional marketing for Varian's Oncology business. Under his leadership, net promoter scores reached all-time highs and Varian grew global market share—the results of which will benefit millions of cancer patients and providers for years to come.

Mr. Toth holds a BA in Business Administration with a concentration in Marketing from the Lundquist College of Business at University of Oregon.